Uremic lung.
Grassi V, Malerba M, Boni E, Tantucci C, Sorbini CA.
Contrib Nephrol. 1994;106:36-42. doi: 10.1159/000422922.
Complement system activation: bridging physiology, pathophysiology, and therapy.
Azoulay E, Zuber J, Bousfiha AA, Long Y, Tan Y, Luo S, Essafti M, Annane D.
Intensive Care Med. 2024 Nov;50(11):1791-1803. doi: 10.1007/s00134-024-07611-4. Epub 2024 Sep 10.
Therapeutic Targeting of the Complement System: From Rare Diseases to Pandemics.
Garred P, Tenner AJ, Mollnes TE.
Pharmacol Rev. 2021 Apr;73(2):792-827. doi: 10.1124/pharmrev.120.000072.
The genus Aeromonas: taxonomy, pathogenicity, and infection.
Janda JM, Abbott SL.
Clin Microbiol Rev. 2010 Jan;23(1):35-73. doi: 10.1128/CMR.00039-09.
Uremic lung: The "calcified cauliflower" sign in the end stage renal disease.
Dilorenzo G, Telegrafo M, Marano G, De Ceglie M, Stabile Ianora AA, Angelelli G, Moschetta M.
Respir Med Case Rep. 2016 Oct 6;19:159-161. doi: 10.1016/j.rmcr.2016.10.003. eCollection 2016.
Uremic lung: new insights into a forgotten condition.
Scheel PJ, Liu M, Rabb H.
Kidney Int. 2008 Oct;74(7):849-51. doi: 10.1038/ki.2008.390.
The survival of B cells is compromised in kidney disease.
Peroumal D, Jawale CV, Choi W, Rahimi H, Antos D, Li DD, Wang S, Manakkat Vijay GK, Mehta I, West R, Thangaraju M, Nolin TD, Das J, Alcorn JF, Biswas PS.
Nat Commun. 2024 Dec 30;15(1):10842. doi: 10.1038/s41467-024-55187-w.
Advances in Understanding of Pathogenesis and Treatment of Immune-Mediated Kidney Disease: A Review.
Kant S, Kronbichler A, Sharma P, Geetha D.
Am J Kidney Dis. 2022 Apr;79(4):582-600. doi: 10.1053/j.ajkd.2021.07.019. Epub 2021 Sep 8.
Cardiovascular Consequences of Uremic Metabolites: an Overview of the Involved Signaling Pathways.
Curaj A, Vanholder R, Loscalzo J, Quach K, Wu Z, Jankowski V, Jankowski J.
Circ Res. 2024 Mar;134(5):592-613. doi: 10.1161/CIRCRESAHA.123.324001. Epub 2024 Feb 29.
Renal-pulmonary crosstalk.
Singbartl K.
Contrib Nephrol. 2011;174:65-70. doi: 10.1159/000329237. Epub 2011 Sep 9.
